Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) Equity Average (2016 - 2026)

Apyx Medical filings provide 15 years of Equity Average readings, the most recent being $10.3 million for Q4 2025.

  • On a quarterly basis, Equity Average fell 19.24% to $10.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.3 million, a 19.24% decrease, with the full-year FY2025 number at $14.4 million, down 30.01% from a year prior.
  • Equity Average hit $10.3 million in Q4 2025 for Apyx Medical, up from $6.8 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $62.0 million in Q1 2021 to a low of $6.8 million in Q3 2025.
  • Median Equity Average over the past 5 years was $35.8 million (2023), compared with a mean of $33.0 million.
  • Biggest five-year swings in Equity Average: fell 12.46% in 2021 and later crashed 62.85% in 2024.
  • Apyx Medical's Equity Average stood at $54.3 million in 2021, then dropped by 26.37% to $40.0 million in 2022, then fell by 24.37% to $30.3 million in 2023, then tumbled by 57.8% to $12.8 million in 2024, then decreased by 19.24% to $10.3 million in 2025.
  • The last three reported values for Equity Average were $10.3 million (Q4 2025), $6.8 million (Q3 2025), and $9.0 million (Q2 2025) per Business Quant data.